Overview

Topiramate-Phentermine Combinations for Cocaine Dependence

Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
0
Participant gender:
All
Summary
This study will determine the influence of topiramate (Topamax®) and phentermine (Adipex®), alone and in combination, on the reinforcing, subjective and physiological effects of cocaine.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Kentucky
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Phentermine
Topiramate
Criteria
Inclusion Criteria:

- Recent cocaine use by the intranasal or intravenous route

Exclusion Criteria:

- Abnormal screening outcome (e.g., ECG, blood chemistry result) that study physicians
deem clinically significant

- Current or past histories of substance abuse or dependence that are deemed by the
study physicians to interfere with study completion

- History of serious physical disease, current physical disease, impaired cardiovascular
functioning, chronic obstructive pulmonary disease, history of seizure or current or
past histories of serious psychiatric disorder that in the opinion of the study
physician would interfere with study participation will be excluded from participation

- Females not currently using effective birth control

- Contraindications to cocaine, topiramate or phentermine